Cellectis (CLLS) Profit After Tax (2014 - 2026)

Cellectis (CLLS) recorded quarterly Profit After Tax of -$17.8 million in Q1 2026, up 32.5% quarter-over-quarter from -$26.3 million in Q4 2025, and up 2.0% on a YoY basis from -$17.4 million in Q1 2025.

Cellectis (CLLS) Profit After Tax (2014 - 2026) Analysis & Trends

Cellectis' Profit After Tax history runs 13 years deep, the most recent figure standing at -$17.8 million for Q1 2026.

  • In Q1 2026, Profit After Tax rose 2.0% year-over-year to -$17.8 million; the TTM figure through Mar 2026 stood at -$56.3 million (up 35.79% YoY), while the FY2025 annual figure was -$67.6 million, down 83.87% from the prior year.
  • Profit After Tax was -$17.8 million for Q1 2026 at Cellectis, up from -$26.3 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $5.9 million in Q4 2024 to a low of -$58.2 million in Q3 2023.
  • Historically, Profit After Tax has averaged -$29.5 million across 5 years, with a median of -$31.3 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 117.35% in 2024, then tumbled 544.41% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$28.6 million in 2022, then tumbled by 75.73% to -$50.2 million in 2023, then surged by 111.8% to $5.9 million in 2024, then sank by 544.41% to -$26.3 million in 2025, then jumped by 32.5% to -$17.8 million in 2026.
  • The last three Profit After Tax figures came in at -$17.8 million (Q1 2026), -$26.3 million (Q4 2025), and -$41.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -753,254.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.74 Mn
10 Cellectis 17.40 Bn 17.21 Bn - -17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.77 Mn
Dec 31, 2025 -26.32 Mn
Sep 30, 2025 -41.28 Mn
Jun 30, 2025 -41.86 Mn
Mar 31, 2025 -18.13 Mn
Dec 31, 2024 5.92 Mn
Sep 30, 2024 -42.68 Mn
Jun 30, 2024 -25.27 Mn
Mar 31, 2024 5.64 Mn
Dec 31, 2023 -50.19 Mn
Sep 30, 2023 -58.20 Mn
Jun 30, 2023 -16.64 Mn
Mar 31, 2023 -32.53 Mn
Dec 31, 2022 -28.56 Mn
Sep 30, 2022 -31.27 Mn
Jun 30, 2022 -50.86 Mn
Mar 31, 2022 -31.91 Mn
Dec 31, 2021 -28.08 Mn
Sep 30, 2021 -40.07 Mn
Jun 30, 2021 -51.79 Mn